Lithuania Caps Off Decade Of Growth With Stellar 2020
Life Sciences Expected Soon To Reach 5% Of GDP
Executive Summary
Lithuania’s life sciences sector has harnessed the country’s talent, infrastructure and government support to realize a decade of unprecedented growth. With the industry now maturing, can the Baltic state overcome challenges to become a significant European player?
You may also be interested in...
Biotech Foundations: Networks And Lab Space Are As Crucial As Funding
BioInnovation Institute chief business officer Bobby Soni shares how the life sciences incubator sources entrepreneurs and science globally, and the range of tools it provides to translate this into commercially viable companies.
Execs On The Move, September 2021
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: New CEOs At ReWind And Esker Therapeutics
Hyloris picks up new chief financial officer, new chief medical officer joins Cyclo and more.